 | • レポートコード：MRC2Q12-19401 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、注射用メシル酸ロピバカインの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に注射用メシル酸ロピバカインのグローバル市場のxxx％を占める「10ml/ピース」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 注射用メシル酸ロピバカインの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの注射用メシル酸ロピバカイン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 注射用メシル酸ロピバカインのグローバル主要プレイヤーには、Shanxi PUDE Pharmaceutical、Cisen Pharmaceutical、Hainan Star Pharmaceutical、Anhui Weiman Pharmaceutical、Yangtze River Pharmaceutical、Zhejiang Hailisheng Pharmaceutical、Jiangsu Nhwa Pharmaceutical、Xi`an Han Feng Pharmaceutical、Shandong New Time Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用メシル酸ロピバカイン市場は、種類と用途によって区分されます。世界の注射用メシル酸ロピバカイン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 10ml/ピース、20ml/ピース 【用途別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用メシル酸ロピバカイン製品概要 - 種類別市場（10ml/ピース、20ml/ピース） - 用途別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用メシル酸ロピバカイン販売量予測2017-2028 - 世界の注射用メシル酸ロピバカイン売上予測2017-2028 - 注射用メシル酸ロピバカインの地域別販売量 - 注射用メシル酸ロピバカインの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用メシル酸ロピバカイン販売量 - 主要メーカー別注射用メシル酸ロピバカイン売上 - 主要メーカー別注射用メシル酸ロピバカイン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（10ml/ピース、20ml/ピース） - 注射用メシル酸ロピバカインの種類別販売量 - 注射用メシル酸ロピバカインの種類別売上 - 注射用メシル酸ロピバカインの種類別価格 ・用途別市場規模（病院薬局、小売店薬局、その他） - 注射用メシル酸ロピバカインの用途別販売量 - 注射用メシル酸ロピバカインの用途別売上 - 注射用メシル酸ロピバカインの用途別価格 ・北米市場 - 北米の注射用メシル酸ロピバカイン市場規模（種類別、用途別） - 主要国別の注射用メシル酸ロピバカイン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用メシル酸ロピバカイン市場規模（種類別、用途別） - 主要国別の注射用メシル酸ロピバカイン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用メシル酸ロピバカイン市場規模（種類別、用途別） - 主要国別の注射用メシル酸ロピバカイン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用メシル酸ロピバカイン市場規模（種類別、用途別） - 主要国別の注射用メシル酸ロピバカイン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用メシル酸ロピバカイン市場規模（種類別、用途別） - 主要国別の注射用メシル酸ロピバカイン市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi PUDE Pharmaceutical、Cisen Pharmaceutical、Hainan Star Pharmaceutical、Anhui Weiman Pharmaceutical、Yangtze River Pharmaceutical、Zhejiang Hailisheng Pharmaceutical、Jiangsu Nhwa Pharmaceutical、Xi`an Han Feng Pharmaceutical、Shandong New Time Pharmaceutical ・産業チェーン及び販売チャネル分析 - 注射用メシル酸ロピバカインの産業チェーン分析 - 注射用メシル酸ロピバカインの原材料 - 注射用メシル酸ロピバカインの生産プロセス - 注射用メシル酸ロピバカインの販売及びマーケティング - 注射用メシル酸ロピバカインの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用メシル酸ロピバカインの産業動向 - 注射用メシル酸ロピバカインのマーケットドライバー - 注射用メシル酸ロピバカインの課題 - 注射用メシル酸ロピバカインの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Ropivacaine Mesylate for Injection Market
Due to the COVID-19 pandemic, the global Ropivacaine Mesylate for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 10ml/Piece accounting for % of the Ropivacaine Mesylate for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Ropivacaine Mesylate for Injection market size is valued at US$ million in 2021, while the US and Europe Ropivacaine Mesylate for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ropivacaine Mesylate for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ropivacaine Mesylate for Injection include Shanxi PUDE Pharmaceutical, Cisen Pharmaceutical, Hainan Star Pharmaceutical, Anhui Weiman Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Hailisheng Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Xi`an Han Feng Pharmaceutical and Shandong New Time Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ropivacaine Mesylate for Injection Scope and Segment
Ropivacaine Mesylate for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Ropivacaine Mesylate for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
10ml/Piece
20ml/Piece
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Shanxi PUDE Pharmaceutical
Cisen Pharmaceutical
Hainan Star Pharmaceutical
Anhui Weiman Pharmaceutical
Yangtze River Pharmaceutical
Zhejiang Hailisheng Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Xi`an Han Feng Pharmaceutical
Shandong New Time Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Ropivacaine Mesylate for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Ropivacaine Mesylate for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 10ml/Piece
1.2.3 20ml/Piece
1.3 Market by Application
1.3.1 Global Ropivacaine Mesylate for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ropivacaine Mesylate for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Ropivacaine Mesylate for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Ropivacaine Mesylate for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ropivacaine Mesylate for Injection Sales by Region
2.4.1 Global Ropivacaine Mesylate for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Ropivacaine Mesylate for Injection by Region (2023-2028)
2.5 Global Ropivacaine Mesylate for Injection Revenue by Region
2.5.1 Global Ropivacaine Mesylate for Injection Revenue by Region (2017-2022)
2.5.2 Global Ropivacaine Mesylate for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ropivacaine Mesylate for Injection Sales by Manufacturers
3.1.1 Global Top Ropivacaine Mesylate for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Ropivacaine Mesylate for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ropivacaine Mesylate for Injection in 2021
3.2 Global Ropivacaine Mesylate for Injection Revenue by Manufacturers
3.2.1 Global Ropivacaine Mesylate for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Ropivacaine Mesylate for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ropivacaine Mesylate for Injection Revenue in 2021
3.3 Global Ropivacaine Mesylate for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ropivacaine Mesylate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ropivacaine Mesylate for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Ropivacaine Mesylate for Injection Sales by Specification
4.1.1 Global Ropivacaine Mesylate for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Ropivacaine Mesylate for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Ropivacaine Mesylate for Injection Revenue by Specification
4.2.1 Global Ropivacaine Mesylate for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Ropivacaine Mesylate for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Ropivacaine Mesylate for Injection Price by Specification
4.3.1 Global Ropivacaine Mesylate for Injection Price by Specification (2017-2022)
4.3.2 Global Ropivacaine Mesylate for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Ropivacaine Mesylate for Injection Sales by Application
5.1.1 Global Ropivacaine Mesylate for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Ropivacaine Mesylate for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
5.2 Global Ropivacaine Mesylate for Injection Revenue by Application
5.2.1 Global Ropivacaine Mesylate for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Ropivacaine Mesylate for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Ropivacaine Mesylate for Injection Price by Application
5.3.1 Global Ropivacaine Mesylate for Injection Price by Application (2017-2022)
5.3.2 Global Ropivacaine Mesylate for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ropivacaine Mesylate for Injection Market Size by Specification
6.1.1 North America Ropivacaine Mesylate for Injection Sales by Specification (2017-2028)
6.1.2 North America Ropivacaine Mesylate for Injection Revenue by Specification (2017-2028)
6.2 North America Ropivacaine Mesylate for Injection Market Size by Application
6.2.1 North America Ropivacaine Mesylate for Injection Sales by Application (2017-2028)
6.2.2 North America Ropivacaine Mesylate for Injection Revenue by Application (2017-2028)
6.3 North America Ropivacaine Mesylate for Injection Market Size by Country
6.3.1 North America Ropivacaine Mesylate for Injection Sales by Country (2017-2028)
6.3.2 North America Ropivacaine Mesylate for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ropivacaine Mesylate for Injection Market Size by Specification
7.1.1 Europe Ropivacaine Mesylate for Injection Sales by Specification (2017-2028)
7.1.2 Europe Ropivacaine Mesylate for Injection Revenue by Specification (2017-2028)
7.2 Europe Ropivacaine Mesylate for Injection Market Size by Application
7.2.1 Europe Ropivacaine Mesylate for Injection Sales by Application (2017-2028)
7.2.2 Europe Ropivacaine Mesylate for Injection Revenue by Application (2017-2028)
7.3 Europe Ropivacaine Mesylate for Injection Market Size by Country
7.3.1 Europe Ropivacaine Mesylate for Injection Sales by Country (2017-2028)
7.3.2 Europe Ropivacaine Mesylate for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ropivacaine Mesylate for Injection Market Size by Specification
8.1.1 Asia Pacific Ropivacaine Mesylate for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Ropivacaine Mesylate for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Ropivacaine Mesylate for Injection Market Size by Application
8.2.1 Asia Pacific Ropivacaine Mesylate for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Ropivacaine Mesylate for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Ropivacaine Mesylate for Injection Market Size by Region
8.3.1 Asia Pacific Ropivacaine Mesylate for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Ropivacaine Mesylate for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ropivacaine Mesylate for Injection Market Size by Specification
9.1.1 Latin America Ropivacaine Mesylate for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Ropivacaine Mesylate for Injection Revenue by Specification (2017-2028)
9.2 Latin America Ropivacaine Mesylate for Injection Market Size by Application
9.2.1 Latin America Ropivacaine Mesylate for Injection Sales by Application (2017-2028)
9.2.2 Latin America Ropivacaine Mesylate for Injection Revenue by Application (2017-2028)
9.3 Latin America Ropivacaine Mesylate for Injection Market Size by Country
9.3.1 Latin America Ropivacaine Mesylate for Injection Sales by Country (2017-2028)
9.3.2 Latin America Ropivacaine Mesylate for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Ropivacaine Mesylate for Injection Market Size by Specification
10.1.1 Middle East and Africa Ropivacaine Mesylate for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Ropivacaine Mesylate for Injection Market Size by Application
10.2.1 Middle East and Africa Ropivacaine Mesylate for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Ropivacaine Mesylate for Injection Market Size by Country
10.3.1 Middle East and Africa Ropivacaine Mesylate for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi PUDE Pharmaceutical
11.1.1 Shanxi PUDE Pharmaceutical Corporation Information
11.1.2 Shanxi PUDE Pharmaceutical Overview
11.1.3 Shanxi PUDE Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi PUDE Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi PUDE Pharmaceutical Recent Developments
11.2 Cisen Pharmaceutical
11.2.1 Cisen Pharmaceutical Corporation Information
11.2.2 Cisen Pharmaceutical Overview
11.2.3 Cisen Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cisen Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cisen Pharmaceutical Recent Developments
11.3 Hainan Star Pharmaceutical
11.3.1 Hainan Star Pharmaceutical Corporation Information
11.3.2 Hainan Star Pharmaceutical Overview
11.3.3 Hainan Star Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hainan Star Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hainan Star Pharmaceutical Recent Developments
11.4 Anhui Weiman Pharmaceutical
11.4.1 Anhui Weiman Pharmaceutical Corporation Information
11.4.2 Anhui Weiman Pharmaceutical Overview
11.4.3 Anhui Weiman Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Anhui Weiman Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Anhui Weiman Pharmaceutical Recent Developments
11.5 Yangtze River Pharmaceutical
11.5.1 Yangtze River Pharmaceutical Corporation Information
11.5.2 Yangtze River Pharmaceutical Overview
11.5.3 Yangtze River Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Yangtze River Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yangtze River Pharmaceutical Recent Developments
11.6 Zhejiang Hailisheng Pharmaceutical
11.6.1 Zhejiang Hailisheng Pharmaceutical Corporation Information
11.6.2 Zhejiang Hailisheng Pharmaceutical Overview
11.6.3 Zhejiang Hailisheng Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zhejiang Hailisheng Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zhejiang Hailisheng Pharmaceutical Recent Developments
11.7 Jiangsu Nhwa Pharmaceutical
11.7.1 Jiangsu Nhwa Pharmaceutical Corporation Information
11.7.2 Jiangsu Nhwa Pharmaceutical Overview
11.7.3 Jiangsu Nhwa Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jiangsu Nhwa Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Nhwa Pharmaceutical Recent Developments
11.8 Xi`an Han Feng Pharmaceutical
11.8.1 Xi`an Han Feng Pharmaceutical Corporation Information
11.8.2 Xi`an Han Feng Pharmaceutical Overview
11.8.3 Xi`an Han Feng Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Xi`an Han Feng Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Xi`an Han Feng Pharmaceutical Recent Developments
11.9 Shandong New Time Pharmaceutical
11.9.1 Shandong New Time Pharmaceutical Corporation Information
11.9.2 Shandong New Time Pharmaceutical Overview
11.9.3 Shandong New Time Pharmaceutical Ropivacaine Mesylate for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shandong New Time Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shandong New Time Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ropivacaine Mesylate for Injection Industry Chain Analysis
12.2 Ropivacaine Mesylate for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ropivacaine Mesylate for Injection Production Mode & Process
12.4 Ropivacaine Mesylate for Injection Sales and Marketing
12.4.1 Ropivacaine Mesylate for Injection Sales Channels
12.4.2 Ropivacaine Mesylate for Injection Distributors
12.5 Ropivacaine Mesylate for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ropivacaine Mesylate for Injection Industry Trends
13.2 Ropivacaine Mesylate for Injection Market Drivers
13.3 Ropivacaine Mesylate for Injection Market Challenges
13.4 Ropivacaine Mesylate for Injection Market Restraints
14 Key Findings in The Global Ropivacaine Mesylate for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Ropivacaine Mesylate for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10ml/Piece
Table 3. Major Manufacturers of 20ml/Piece
Table 4. Global Ropivacaine Mesylate for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Ropivacaine Mesylate for Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Ropivacaine Mesylate for Injection Sales by Region (2017-2022) & (K Units)
Table 7. Global Ropivacaine Mesylate for Injection Sales Market Share by Region (2017-2022)
Table 8. Global Ropivacaine Mesylate for Injection Sales by Region (2023-2028) & (K Units)
Table 9. Global Ropivacaine Mesylate for Injection Sales Market Share by Region (2023-2028)
Table 10. Global Ropivacaine Mesylate for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Ropivacaine Mesylate for Injection Revenue Market Share by Region (2017-2022)
Table 12. Global Ropivacaine Mesylate for Injection Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Ropivacaine Mesylate for Injection Revenue Market Share by Region (2023-2028)
Table 14. Global Ropivacaine Mesylate for Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Ropivacaine Mesylate for Injection Sales Share by Manufacturers (2017-2022)
Table 16. Global Ropivacaine Mesylate for Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Ropivacaine Mesylate for Injection Revenue Share by Manufacturers (2017-2022)
Table 18. Ropivacaine Mesylate for Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Ropivacaine Mesylate for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Ropivacaine Mesylate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ropivacaine Mesylate for Injection as of 2021)
Table 21. Ropivacaine Mesylate for Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Ropivacaine Mesylate for Injection Product Offered
Table 23. Date of Manufacturers Enter into Ropivacaine Mesylate for Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 26. Global Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 27. Global Ropivacaine Mesylate for Injection Sales Share by Specification (2017-2022)
Table 28. Global Ropivacaine Mesylate for Injection Sales Share by Specification (2023-2028)
Table 29. Global Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 30. Global Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 31. Global Ropivacaine Mesylate for Injection Revenue Share by Specification (2017-2022)
Table 32. Global Ropivacaine Mesylate for Injection Revenue Share by Specification (2023-2028)
Table 33. Ropivacaine Mesylate for Injection Price by Specification (2017-2022) & (US$/Unit)
Table 34. Global Ropivacaine Mesylate for Injection Price Forecast by Specification (2023-2028) & (US$/Unit)
Table 35. Global Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 36. Global Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 37. Global Ropivacaine Mesylate for Injection Sales Share by Application (2017-2022)
Table 38. Global Ropivacaine Mesylate for Injection Sales Share by Application (2023-2028)
Table 39. Global Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Ropivacaine Mesylate for Injection Revenue Share by Application (2017-2022)
Table 42. Global Ropivacaine Mesylate for Injection Revenue Share by Application (2023-2028)
Table 43. Ropivacaine Mesylate for Injection Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Ropivacaine Mesylate for Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 46. North America Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 47. North America Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 48. North America Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 49. North America Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 50. North America Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 51. North America Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Ropivacaine Mesylate for Injection Sales by Country (2017-2022) & (K Units)
Table 54. North America Ropivacaine Mesylate for Injection Sales by Country (2023-2028) & (K Units)
Table 55. North America Ropivacaine Mesylate for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Ropivacaine Mesylate for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 58. Europe Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 59. Europe Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 60. Europe Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 61. Europe Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 62. Europe Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 63. Europe Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Ropivacaine Mesylate for Injection Sales by Country (2017-2022) & (K Units)
Table 66. Europe Ropivacaine Mesylate for Injection Sales by Country (2023-2028) & (K Units)
Table 67. Europe Ropivacaine Mesylate for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Ropivacaine Mesylate for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 70. Asia Pacific Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 71. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 72. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 73. Asia Pacific Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Ropivacaine Mesylate for Injection Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Ropivacaine Mesylate for Injection Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Ropivacaine Mesylate for Injection Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 82. Latin America Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 83. Latin America Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 84. Latin America Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 85. Latin America Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Ropivacaine Mesylate for Injection Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Ropivacaine Mesylate for Injection Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Ropivacaine Mesylate for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Ropivacaine Mesylate for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Specification (2017-2022) & (K Units)
Table 94. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Specification (2023-2028) & (K Units)
Table 95. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Specification (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Specification (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Ropivacaine Mesylate for Injection Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Ropivacaine Mesylate for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 105. Shanxi PUDE Pharmaceutical Corporation Information
Table 106. Shanxi PUDE Pharmaceutical Description and Major Businesses
Table 107. Shanxi PUDE Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Shanxi PUDE Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Shanxi PUDE Pharmaceutical Recent Developments
Table 110. Cisen Pharmaceutical Corporation Information
Table 111. Cisen Pharmaceutical Description and Major Businesses
Table 112. Cisen Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Cisen Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Cisen Pharmaceutical Recent Developments
Table 115. Hainan Star Pharmaceutical Corporation Information
Table 116. Hainan Star Pharmaceutical Description and Major Businesses
Table 117. Hainan Star Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Hainan Star Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Hainan Star Pharmaceutical Recent Developments
Table 120. Anhui Weiman Pharmaceutical Corporation Information
Table 121. Anhui Weiman Pharmaceutical Description and Major Businesses
Table 122. Anhui Weiman Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Anhui Weiman Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Anhui Weiman Pharmaceutical Recent Developments
Table 125. Yangtze River Pharmaceutical Corporation Information
Table 126. Yangtze River Pharmaceutical Description and Major Businesses
Table 127. Yangtze River Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Yangtze River Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Yangtze River Pharmaceutical Recent Developments
Table 130. Zhejiang Hailisheng Pharmaceutical Corporation Information
Table 131. Zhejiang Hailisheng Pharmaceutical Description and Major Businesses
Table 132. Zhejiang Hailisheng Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Zhejiang Hailisheng Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Zhejiang Hailisheng Pharmaceutical Recent Developments
Table 135. Jiangsu Nhwa Pharmaceutical Corporation Information
Table 136. Jiangsu Nhwa Pharmaceutical Description and Major Businesses
Table 137. Jiangsu Nhwa Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Jiangsu Nhwa Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Jiangsu Nhwa Pharmaceutical Recent Developments
Table 140. Xi`an Han Feng Pharmaceutical Corporation Information
Table 141. Xi`an Han Feng Pharmaceutical Description and Major Businesses
Table 142. Xi`an Han Feng Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Xi`an Han Feng Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Xi`an Han Feng Pharmaceutical Recent Developments
Table 145. Shandong New Time Pharmaceutical Corporation Information
Table 146. Shandong New Time Pharmaceutical Description and Major Businesses
Table 147. Shandong New Time Pharmaceutical Ropivacaine Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Shandong New Time Pharmaceutical Ropivacaine Mesylate for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Shandong New Time Pharmaceutical Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Ropivacaine Mesylate for Injection Distributors List
Table 153. Ropivacaine Mesylate for Injection Customers List
Table 154. Ropivacaine Mesylate for Injection Market Trends
Table 155. Ropivacaine Mesylate for Injection Market Drivers
Table 156. Ropivacaine Mesylate for Injection Market Challenges
Table 157. Ropivacaine Mesylate for Injection Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Ropivacaine Mesylate for Injection Product Picture
Figure 3. Global Ropivacaine Mesylate for Injection Market Share by Specification in 2021 & 2028
Figure 3. 10ml/Piece Product Picture
Figure 4. 20ml/Piece Product Picture
Figure 5. Global Ropivacaine Mesylate for Injection Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Others
Figure 9. Ropivacaine Mesylate for Injection Report Years Considered
Figure 10. Global Ropivacaine Mesylate for Injection Sales 2017-2028 (K Units)
Figure 11. Global Ropivacaine Mesylate for Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ropivacaine Mesylate for Injection Revenue 2017-2028 (US$ Million)
Figure 13. Global Ropivacaine Mesylate for Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Ropivacaine Mesylate for Injection Sales Market Share by Region (2017-2022)
Figure 15. Global Ropivacaine Mesylate for Injection Sales Market Share by Region (2023-2028)
Figure 16. North America Ropivacaine Mesylate for Injection Sales YoY (2017-2028) & (K Units)
Figure 17. North America Ropivacaine Mesylate for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Ropivacaine Mesylate for Injection Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Ropivacaine Mesylate for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Ropivacaine Mesylate for Injection Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Ropivacaine Mesylate for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Ropivacaine Mesylate for Injection Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Ropivacaine Mesylate for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Ropivacaine Mesylate for Injection Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Ropivacaine Mesylate for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Ropivacaine Mesylate for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Ropivacaine Mesylate for Injection in the World: Market Share by Ropivacaine Mesylate for Injection Revenue in 2021
Figure 28. Global Ropivacaine Mesylate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 30. Global Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 31. Global Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 32. Global Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 33. North America Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 34. North America Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 35. North America Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 36. North America Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 37. North America Ropivacaine Mesylate for Injection Sales Share by Country (2017-2028)
Figure 38. North America Ropivacaine Mesylate for Injection Revenue Share by Country (2017-2028)
Figure 39. United States Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 42. Europe Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 43. Europe Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 45. Europe Ropivacaine Mesylate for Injection Sales Share by Country (2017-2028)
Figure 46. Europe Ropivacaine Mesylate for Injection Revenue Share by Country (2017-2028)
Figure 47. Germany Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 48. France Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 53. Asia Pacific Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 54. Asia Pacific Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Ropivacaine Mesylate for Injection Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Ropivacaine Mesylate for Injection Revenue Share by Region (2017-2028)
Figure 58. China Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 61. India Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 68. Latin America Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 69. Latin America Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 70. Latin America Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Ropivacaine Mesylate for Injection Sales Share by Country (2017-2028)
Figure 72. Latin America Ropivacaine Mesylate for Injection Revenue Share by Country (2017-2028)
Figure 73. Mexico Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Ropivacaine Mesylate for Injection Sales Market Share by Specification (2017-2028)
Figure 78. Middle East and Africa Ropivacaine Mesylate for Injection Revenue Market Share by Specification (2017-2028)
Figure 79. Middle East and Africa Ropivacaine Mesylate for Injection Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Ropivacaine Mesylate for Injection Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Ropivacaine Mesylate for Injection Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Ropivacaine Mesylate for Injection Revenue Share by Country (2017-2028)
Figure 83. Turkey Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Ropivacaine Mesylate for Injection Revenue (2017-2028) & (US$ Million)
Figure 86. Ropivacaine Mesylate for Injection Value Chain
Figure 87. Ropivacaine Mesylate for Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed